These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 4178383)
1. The timing of sensitisation and its relevance to the prevention of Rh-haemolytic disease. Finn R; Clarke CA Bibl Haematol; 1968; 29():267-72. PubMed ID: 4178383 [No Abstract] [Full Text] [Related]
2. [Prevention of feto-maternal isoimmunization, in particular by means of anti-Rh immunoglobulins]. de Muralt G Rev Fr Transfus; 1969 Mar; 12(1):61-84. PubMed ID: 4180270 [No Abstract] [Full Text] [Related]
3. [Prevention of hemolytic disease of the newborn with human anti-RH-D immunoglobulin]. Hollán SR Rev Fr Transfus; 1969 Sep; 12(3):319-39. PubMed ID: 4190597 [No Abstract] [Full Text] [Related]
4. Prevention of Rh immunization in Finland. A national study, 1969--1977. Eklund J Acta Paediatr Scand Suppl; 1978; (274):1-57. PubMed ID: 82366 [No Abstract] [Full Text] [Related]
5. Rh immunisation and its prevention. Woodrow JC Ser Haematol; 1970; 3(3):1-151. PubMed ID: 4109155 [No Abstract] [Full Text] [Related]
6. Prevention and treatment of erythroblastosis fetalis. Levine P Ann N Y Acad Sci; 1970 Feb; 169(1):234-40. PubMed ID: 4189997 [No Abstract] [Full Text] [Related]
7. [Rhesus sensitization and prevention with anti-D-immunoglobulin]. Hindemann P; Hinselmann M; Frey P Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763 [No Abstract] [Full Text] [Related]